Weight-loss drugs such as Ozempic or Wegovy and Zepbound are being hailed as game-changers in obesity treatment. However, these medications only work to a point; patients quickly lose weight initially, but this slows down and eventually comes to a halt. The pharmaceutical industry looks set to explore further advances in gut hormone-related drugs for weight loss. The aim is to gradually decrease the ‘plateau’ point to achieve greater weight loss. Drugs that stimulate multiple gut hormones could be the key, alongside increased dosages.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
